Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indo Straits Tbk. (PTIS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Indo Straits Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Indo Straits Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Indo Straits Tbk. trades at Rp260 (market cap 144.14B, 66.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 85.7× Indo Straits Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.41M versus 66.9K). Which is the better fit depends on your goals.

PTISTSPC
Market Cap
144.14B12.36T
Volume
66.9K1.41M
Lot
66914.08K
Turnover
17.5M3.83B
Average Price
261.642,722.04
Value
17.5M3.83B
Indicative Equilibrium Price
2602,730
Indicative Equilibrium Volume
202.51K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PTIS
View details
TSPC
View details

About Indo Straits Tbk.

PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.

Read more on PTIS

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC